Brown: Risk Weighti...
Health Care: Drugs
Bristol-Myers Squibb Company (BMY: NYSE)
$43.30 0.53 | 1.24%
05/17/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | 2.50B | 5.26B | 4.51B | 11.86B |
| Operating Gains/Losses | 0.00 | 0.00 | -1.44B | -1.25B |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 648.00M | -220.00M | -270.00M | 227.00M |
| (Increase) Decrease in Inventories | -103.00M | -193.00M | 156.00M | 82.00M |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | -232.00M | 593.00M | 315.00M | 472.00M |
| (Decrease) Increase In Other Current Liabilities | -50.00M | -134.00M | -236.00M | 58.00M |
| (Increase) Decrease In Other Working Capital | -602.00M | -173.00M | -131.00M | -797.00M |
| Other Non-Cash Items | 5.33B | -1.51B | 421.00M | -7.46B |
| Net Cash From Continuing Operations | 6.94B | 4.84B | 4.49B | 4.06B |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | 6.94B | 4.84B | 4.49B | 4.06B |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 67.00M | 557.00M |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 4.89B | 5.96B | 3.20B | 2.08B |
| Purchases of Property, Plant & Equipment | -548.00M | -367.00M | -424.00M | -730.00M |
| Acquisitions | -7.46B | -211.00M | -829.00M | -2.23B |
| Purchases of Short-Term Investments | -3.61B | -6.82B | -5.82B | -3.49B |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | -561.00M |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -6.73B | -1.44B | -3.81B | -4.38B |
| Issuance of Debt | 1.95B | 0.00 | 6.00M | 1.68B |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 463.00M | 601.00M | 252.00M | 827.00M |
| Repayment of Long-Term Debt | -2.11B | -79.00M | -969.00M | -238.00M |
| Repurchase of Capital Stock | -2.40B | -1.22B | -576.00M | 0.00 |
| Payment of Cash Dividends | -2.29B | -2.25B | -2.20B | -2.48B |
| Other Financing Charges, Net | 51.00M | 296.00M | 146.00M | 194.00M |
| Net Cash From Financing Activities | -4.33B | -2.66B | -3.34B | -17.00M |
| Effect of Exchange Rate Changes | -1.00M | -3.00M | 14.00M | 39.00M |
| Net Change in Cash & Cash Equivalents | -4.12B | 743.00M | -2.65B | -293.00M |
Portfolios with BMY
- Portfolio NameUser Type
- ContributorHigh Volume Technicals for ...
- UserThe Best Dividend Stocks
- UserCapt Jer
- Userlennyvb Portfolio 1
- Usersamuel sandler kosher sausage
- ProNavellier & Associates
- ProRenaissance Technologies
- UserHoneypot
- Pondo
- UserJS&JH
Latest BMY Headlines from TheStreet
- Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Winner 05.17.13 | 05:05 pm
- Quick Take: The Next Big Thing in Biotech 05.17.13 | 10:05 am
- Analysts' Actions: AMAT ARUN BMY DE WSM 05.17.13 | 08:05 am
- Biotech's Next Big Thing ASCO II
05.16.13 | 02:05 pm - 5 Stock Trades for S&P 1,700 05.16.13 | 07:05 am
- ASCO '13 Preview: New 'Anti-PD-1' Therapies Shrink Tumors 05.15.13 | 06:05 pm
- 5 Stocks Boosting The Drugs Industry Higher 05.15.13 | 01:05 pm
- Bristol-Myers Squibb Reaches New 52-Week High (BMY) 05.15.13 | 10:05 am
- Bristol-Myers Squibb Company (BMY): Today's Featured Health Care Winner 05.10.13 | 05:05 pm
- Biotech's Next Big Thing: ASCO 05.09.13 | 09:05 am
Press Releases for BMY
- Ambrx Initiates Collaboration With Bristol-Myers Squibb For Discovery, Development Of Next-Generation Antibody Drug Conjugates - PR Newswire 05.03.13 | 08:05 am
- Former Pro Football Coach Bill Cowher Tells Men "No Excuses" When It Comes To Getting Screened For Melanoma - PR Newswire 04.23.13 | 08:04 am
- Santaris Pharma Announces A Worldwide Discovery Alliance With Bristol-Myers Squibb For RNA-targeted Medicines - PR Newswire 04.16.13 | 02:04 am
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Bristol-Myers Squibb Awards Two Grants To Support Comprehensive Cancer Community Collaboration At Several Hospitals In New Jersey - Business Wire 03.13.13 | 09:03 am
- Bristol-Myers Squibb Announces Dividend - Business Wire 03.07.13 | 05:03 pm
- Bristol-Myers Squibb To Present At Barclays Global Health Care Conference - Business Wire 03.05.13 | 04:03 pm
- Bristol-Myers Squibb To Present At Cowen And Company Health Care Conference - Business Wire 02.27.13 | 04:02 pm
- Bristol-Myers Squibb To Take Part In Citi 2013 Global Health Care Conference - Business Wire 02.19.13 | 04:02 pm
- Bristol-Myers Squibb Appoints Ann Powell Judge Senior Vice President, Human Resources - Business Wire 02.14.13 | 08:02 am
Partner Headlines for BMY
- Biotech Alkermes Poised To Swell On Pipeline Wins - Investor's Business Daily 04.16.13 | 05:04 pm
- A Flight To Safety Or Crash And Burn? - Seeking Alpha 04.13.13 | 09:04 am
- Parexel Grows Earnings With Big Pharma Partnerships - Investor's Business Daily 04.04.13 | 02:04 pm
- Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for April 03, 2013 - NASDAQ 04.02.13 | 01:04 pm
- Analysts: United Continental is Looking Good and 3 New Opinions Investors Must Read Now - Wall St. Cheat Sheet 04.02.13 | 11:04 am
- Aetna Offloads Business and 4 Stocks At 52-Week Highs - Wall St. Cheat Sheet 04.02.13 | 09:04 am
- 4 Healthcare Stock Stories for Monday Investment Wellness - Wall St. Cheat Sheet 04.01.13 | 02:04 am
- 4 Healthcare Stock Stories for Monday Investment Wellness - Wall St. Cheat Sheet 04.01.13 | 02:04 am
- Team Alpha And The Foundations For Financial Freedom - Seeking Alpha 03.23.13 | 08:03 am
- AstraZeneca puts its faith in science - Financial Times 03.21.13 | 06:03 pm
